PS www.ProStocks.com
|
|
Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.
The competitive strengths of the company are:
1. Customer-centric and order-driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing, and sales network
5. Diversified business operations
| IPO Date | Mar 9, 2023 to Mar 14, 2023 |
| Listing Date | Mar 22, 2023 |
| Face Value | ₹10 per share |
| Price | ₹71 to ₹73 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 6,862,400 shares (aggregating up to ₹50.10 Cr) |
| Fresh Issue | 6,862,400 shares (aggregating up to ₹50.10 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| QIB Shares Offered | 521,600 (8.58%) |
| NII (HNI) Shares Offered | 1,908,800 (31.39%) |
| Retail Shares Offered | 3,651,200 (60.04%) |
| Market Maker portion | 344,000 shares (GRETEX SHARE BROKING PVT. LTD.) |
| Anchor Investor Shares Offered | 780,800 |
| Total Shares Offered | 6,081,600 |
Sudarshan Pharma Industries IPO Anchor Investors list
| Bid Date | Mar 8, 2023 |
| Shares Offered | 780,800 |
| Anchor Portion Size (In Cr.) | 5.70 |
| Anchor lock-in period end date for 50% shares (30 Days) | May 5, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | Jul 31, 2023 |
Sudarshan Pharma Industries IPO opens on Mar 9, 2023, and closes on Mar 14, 2023.
| Event | Tentative Date |
|---|---|
| Opening Date | Mar 9, 2023 |
| Closing Date | Mar 14, 2023 |
| Basis of Allotment | Mar 17, 2023 |
| Initiation of Refunds | Mar 20, 2023 |
| Credit of Shares to Demat | Mar 21, 2023 |
| Listing Date | Mar 22, 2023 |
| UPI Mandate Confirmation Cut-Off Time | 5.00 PM on the issue closing day |
The Sudarshan Pharma Industries IPO lot size is 1600 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹116,800 |
| Retail (Max) | 1 | 1600 | ₹116,800 |
| HNI (Min) | 2 | 3,200 | ₹233,600 |
| Lot Size Calculator | |||
Mr. Hemal Vasantrai Mehta and Mr. Sachin Vasantrai Mehta are the Promoters of the company.
| Pre Issue Share Holding | 80.28% |
| Post Issue Share Holding |
The Sudarshan Pharma Industries IPO is subscribed 1.06 times on Mar 14, 2023 7:02:00 PM. The public issue subscribed 1.20 times in the retail category, 1.01 times in the QIB category, and 0.81 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 1.01 |
| NII | 0.81 |
| Retail | 1.20 |
| Total | 1.06 |
Total Application : 3,005 (1.32 times)
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-21 | 9,926.02 | 19,372.82 | 267.12 | 2,250.74 | 1,296.05 | 2,977.09 |
| 31-Mar-22 | 13,752.18 | 35,755.89 | 530.37 | 2,977.53 | 2,002.63 | 3,059.24 |
| 30-Sep-22 | 16,402.22 | 19,589.87 | 360.70 | 5,108.79 | 3,996.89 | 4,940.50 |
| Amount in ₹ Lakhs | ||||||
| KPI | Values |
|---|---|
| P/E (x) | 21.28 |
| Market Cap (₹ Cr.) | 175.68 |
[Dilip Davda] SPIL which failed to sail through its maiden IPO in June 2019 is trying for the second time for nearly double the amount. It is spending whooping Rs. 7.90 cr. (over 10 times projected for the first try) for this IPO process. It has changed the lead manager for this offer and the list of listed peers. Higher borrowings (Rs. 49.41 cr.), and tax notices of Rs. 7.41 cr. (excluding interest/penalty thereon) raises concern. Though it has posted growth in its financial data, it is fully mirrored including the near-term positives in the asking price. Off late we are witnessing a faded out of fancy for the pharma/healthcare segment post-pandemic. There is no harm in skipping this “High-Risk/Low-Return” bet. Read detail review...
The Company intends to utilize the Net Fresh Issue Proceeds for the following Objects:
| Listing Date | Mar 22, 2023 |
| BSE Script Code | 543828 |
| NSE Symbol | |
| ISIN | INE00TV01015 |
| Final Issue Price | ₹73 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE SME |
|---|
| ₹73.00 |
| ₹73.00 |
| ₹69.35 |
| ₹73.25 |
| ₹69.35 |
Sudarshan Pharma Industries Ltd
301,3rd Floor, Aura Biplex,
Above Kalyan Jewellers S. V. Road, Borivali (West)
Mumbai - 400092
Phone: 022- 42221111
Email: compliance@sudarshanpharma.com
Website: http://www.sudarshanpharma.com/
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: einward.ris@kfintech.com
Website: https://karisma.kfintech.com/
Are you an SME company looking for an IPO to raise funds and get listed in the stock market? We can help. Contact us today... SME IPO Enquiry Form
Sudarshan Pharma Industries IPO is a SME IPO of 6,862,400 equity shares of the face value of ₹10 aggregating up to ₹50.10 Crores. The issue is priced at ₹71 to ₹73 per share. The minimum order quantity is 1600 Shares.
The IPO opens on Mar 9, 2023, and closes on Mar 14, 2023.
KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Sudarshan Pharma Industries IPO using UPI as a payment gateway. Zerodha customers can apply in Sudarshan Pharma Industries IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sudarshan Pharma Industries IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sudarshan Pharma Industries IPO opens on Mar 9, 2023 and closes on Mar 14, 2023.
Sudarshan Pharma Industries IPO lot size is 1600 Shares and the minimum order quantity is .
You can apply in Sudarshan Pharma Industries IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Sudarshan Pharma Industries IPO will be done on Mar 17, 2023, and the allotted shares will be credited to your demat account by Mar 21, 2023. Check the Sudarshan Pharma Industries IPO allotment status.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
RHP
